1-Bromo-4-(trifluoromethyl)cyclohexane

Catalog No. :
ACIRSB754
CAS No. :
30129-20-5
Molecular Formula :
C7H10BrF3
Molecular Weight :
231.05

IUPAC Name:1-bromo-4-(trifluoromethyl)cyclohexane

1-Bromo-4-(trifluoromethyl)cyclohexane structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$137.00Login to see priceIn stockInquiry
250mg98%$220.00Login to see priceIn stockInquiry
1g98%$553.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Bromo-4-(trifluoromethyl)cyclohexane
IUPAC Name1-bromo-4-(trifluoromethyl)cyclohexane
MDL No.MFCD20410249
Molecular FormulaC7H10BrF3
Molecular Weight231.05
SMILESFC(C1CCC(Br)CC1)(F)F
InChI KeyCTEBWBSBKSFIMN-UHFFFAOYSA-N
SynonymCTEBWBSBKSFIMN-UHFFFAOYSA-N | SY217636 | CS-0245709 | MFCD20410249 | SCHEMBL17892081 | AKOS014081850 | PS-16475 | 1-bromo-4-(trifluoromethyl)cyclohexane | EN300-309543 | F70990
CAS No.30129-20-5
PubChem CID64753896

Safety Data

Pictogram
FlammableHarmful or irritant
Signal Word
Gefahr
Hazard Statement(s)
H225-H315-H319
Precautionary Statement(s)
P210-P233-P240-P241-P242-P243-P264-P280-P303+P361+P353-P305+P351+P338-P332+P313-P337+P313-P362+P364-P370+P378-P403+P235-P501

Synthetic Route by SureRoute

1. ACIRSB754 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLDCM185 route compound structure diagram
    ACLDCM18530129-18-1 In Stock
  4. Then
  5. ACIRSB754 route product structure diagram
    ACIRSB75430129-20-5 In Stock
Inquiry

2. ACIRSB754 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJSDN037 route compound structure diagram
    ACJSDN0377789-46-0 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIRSB754 route product structure diagram
    ACIRSB75430129-20-5 In Stock
Inquiry

Comments (0)